Articles On LBT Innovations (ASX:LBT)

LBT Innovations (LBT) appoints Thermo Fisher Scientific as its exclusive distributor for the APAS Independence product in EuropeThe move expands LBT’s existing distribution agreement for the APAS Independence to include up to 35 countries g...

ShareCafeOil falls to lowest price since 2021: ASX closes 0.42% lower by Peter Milios   Amidst the ongoing tensions arising from the continuation of China’s lockdowns from their recent COVID surge, oil has fallen to its lowest point since D...

ShareCafeChina’s lockdown rampage causes lower start to ASX by Peter Milios   China’s persistent lockdowns have caused commodity prices and futures to fall. As a result, at noon, the S&P/ASX 200 is 0.34 per cent or 24.50 points lower at...

ASX health stocks have been out of favour this year with rotation away from growth to value sector Morgan’s Scott Power said a lot of biotechs aren’t able to convert their complex science into layman’s terms Hot money going to lithium and...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

ASX200 and small caps end about 0.4% down BNPLs come out of hibernation WA1 is finding even more niobium   Local markets failed to launch on Wednesday, unlike the missile strikes early this morning AEDT, which reportedly crossed the borde...

ShareCafeWebinar Recap – EMH, MCL, WML & LBT Catch up on the full webinar presentations from European Metals (ASX: EMH), Mighty Craft (ASX: MCL), Woomera Mining (ASX: WML) & LBT Innovations (ASX: LBT) Webinar Recap – EMH, MCL, WML...

ShareCafeLBT Innovations (ASX: LBT) – Webinar Presentation Brent Barnes – Managing Director & CEO – LBT Innovations is a groundbreaking designer of advanced technology solutions for the medical industry. LBT Innovations (ASX: LBT) – We...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

ShareCafeStrong finish despite tomorrow’s expected rate hike: ASX closes 1.15% higher by Peter Milios   All eyes are on tomorrow’s expected interest rate hike, with many predicting a 50 basis point rise. To finish the day the S&P/ASX 20...

ShareCafeIT sector rallies to lift the market: ASX up 0.94% at noon The local market has commenced the week in the green with the S&P/ASX 200 up 0.94 per cent or 63.70 points higher to 6,849.40 at noon. This comes off the back of US equ...

ShareCafeEnergy and Materials only sectors left lagging: ASX closes 0.28% higher by Peter Milios   In today’s events, independent commission agency ASIC has launched legal action against BPS Financial, the company behind Gold Coast-based di...

The ASX 200 trims gains to end circa 0.3% higher Small caps drop 0.2%, but C29 Metals booms China markets still choppy after political appointments   The big show, if balancing books and picking pre-chosen soundbytes is your thing, begins...

ShareCafeOptimism out of the US boosts sentiment: ASX up 0.6% at noon by Lauren Hayes   Positive gains in the local market have extended into a second day as optimism out of the US about corporate earnings ahead of several key tech reports...

ShareCafeIT and Materials lead the way: ASX finishes 1.54% higher by Peter Milios   All sectors finished in the green to start the week, with some big results from Australian electric vehicle companies. The ASX companies that were amongst t...

ShareCafeMonday morning rally: ASX up 1.73% at lunch by Lauren Hayes   The Australian market is enjoying a solid start to the trading week after US equities snapped their two-day losing streak and posted solid gains on more strong corporate...

We take a look at how the 15 biotech IPOs that listed in 2021 are faring now Only two IPO stocks from 2021 have gained since listing We also look at the best and worst performing ASX stocks over the past month   There were 191 ASX IPOs in...

ShareCafeLBT Innovations (ASX: LBT) Developing Clean-Room Technology for Pharma Companies LBT Innovations Limited (ASX: LBT) CEO and Managing Director Brent Barnes discusses new opportunities for the company’s automation technology. LBT In...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX Powerplays. Several ASX health stocks have...

US FDA approves the first clinical trial using naturally derived psychedelic drugs It could open possibilities for other clinical trials to follow suit Best and worst biotechs over the past month In a ground-breaking development, the US F...

A recent research reveals which biotech segments VCs are ploughing billions of dollars into We list the ASX companies that are operating within those thematics We also list the best and worst ASX biotech performers over the past week and m...

Avita Medical makes spray on skin for burns and soft tissue injuries HITIQ’s concussion tech is popular for athletes and sports teams PainChek’s smartphone app can tell if babies or older Aussies are in pain There’s a plethora of biotech...

For most medical device companies, selling six instruments within the space of six months would hardly be cause for celebration. But for the Adelaide-based LBT Innovations (ASX:LBT), the sales “inflexion point” was an excuse to crack open a...

Healthcare and life sciences expert Scott Power – a senior analyst with Morgans Financial for 24 years – on what the movers and shakers have been doing in health and which ASX health stocks make Scott’s Powerplays. Are you the cuddly type?...

The interest rate rise came and the markets fell, then turned a corner. The question now is — will the wheels stay on? Already lagging, the ASX Emerging Companies (XEC) index has closed 0.8% lower. The benchmark has closed 0.4% behind. The...

The Healthcare sector has been struggling as the pandemic wanes But most money managers are still bullish on the sector The biggest movements and news from ASX healthcare stocks this week  Dr Anthony Faucci, America’s top infectious disea...

The healthcare sector is experiencing a dry run IPO listings have fallen significantly on weak market appetite  A snapshot of the return of recent ASX Healthcare IPO stocks We are currently in the longest and steepest bear market for biot...

Biotech sector has had a tough time recently But there are signs of things improving this year A look at biotech movers on the ASX in the past fortnight Biotech stocks entered a bear phase in the middle of 2021, and things haven’t improve...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. At the start of trade on Frida...

The ASX Emerging Companies Index (XEC) has ended 1.5% higher on Wednesday, driven by a new EV car as a few battery metal small caps locked in the right prices from a government ready to pay. The ASX200 has also risen a further 1.1% driven b...

LBT Innovations’ (LBT) wholly owned subsidiary Clever Culture Systems (CCS) receives purchase orders for five APAS Independence instruments from its US-based distributor Thermo Fisher Scientific It comes after LBT acquired the remainder of...

Telehealth was already a growing space even before the pandemic, but COVID had launched it into the mainstream. At the height of the pandemic in 2020, data from Research and Markets showed that 76% of hospitals in the US were using teleheal...

The ongoing lawsuit involving Johnson & Johnson (J&J)’s talc products took a controversial turn in the courts this week. The healthcare giant is currently staring down 38,000 claims that its talc products (including the famous baby...

ShareCafeWebinar Recap – TNR, LBT, 1AD & LIT Catch up on the full webinar with presentations from Torian Resources (ASX: TNR), LBT Innovations (ASX: LBT),  Adalta (ASX: 1AD) & Lithium Australia (ASX: LIT) Webinar Recap – TNR...

ShareCafeLBT Innovations (ASX: LBT) – Webinar Presentation Brent Barnes – CEO & Managing Director – LBT Innovations is a groundbreaking designer of advanced technology solutions for the medical industry. LBT Innovations (ASX: LBT) – We...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 25 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week There’s so...

LBT Innovations (LBT) completes the acquisition of Clever Culture Systems (CCS) and now owns 100 per cent On December 29, the company signed a binding agreement with Hettich to acquire its 50 per cent holding in CCS The acquisition consi...

The ASX 200 Health Index (XHJ) is trading higher by 0.30% at the time of writing, compared to the broader index which is also up by 0.87%. Imugene (ASX:IMU) is up by 8% this morning, after confirming that its immunotherapy candidate, PD1-Va...

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

At the time of writing, the ASX XHJ Healthcare index is up 5.55% over the last five trading days, beating the ASX200 benchmark index which was up 2.8% for the period. Here’s a table showing how ASX-listed healthcare stocks have been perform...

LBT Innovations (LBT) signs a binding agreement with Hettich to acquire 50 per cent of Clever Culture Systems (CCS), giving it full ownership The company will pay Hettich $4 million which will be split into $1 million in cash, 30.66 millio...

S&P 500 hovers at record high as COVID-19 cases soar Wall Street closed out a choppy trading session on Tuesday, as the S&P 500 broke a four-day winning streak and closed within a whisker of its all-time high. The S&P 500 index...

It’s been a rocky two weeks for small-cap health companies with 42 gaining ground, 76 losing it, and 21 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. CODE COMPANY PRICE 1 WEEK RETURN %...

It’s been a rocky two weeks for small-cap health companies, with 27 companies gaining ground, 89 losing it and 21 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. Code Name Price % Six Mont...

It’s been a rocky two weeks for small-cap health companies, with 33 companies gaining ground, 86 losing it and 16 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. Code Company Price % Six M...

Highlights AI has the potential to deliver over AU$20 trillion to the global economy by 2030. AI is making progress in fields like healthcare, mining, sales etc. AI Technology presents vast opportunities for people as well as business...

After a positive Monday to Thursday, the ASX wiped out gains made across the week, losing more than 1% today The ASX followed a plunge on Wall Street with the ASX 200 closing at 7,324, which was 1.44% lower than yesterday’s close. While Wal...

LBT Innovations (LBT) is granted FDA clearance for its culture plate reading technology, APAS Independence The clearance enables both the urine and MRSA analysis modules to be sold commercially to customers in the United States The company...

The ASX failed to replicate yesterday’s positive start to the week, falling over 1% today. The ASX 200 closed 1.47% down at 7,726 points while the ASX Emerging Companies Index fell 0.73% closing at 2,537 points. The worst sectors were healt...

The LBT Innovations Limited (ASX: LBT) share price is deep in the red today. This comes regardless of the medical technology company providing investors with a positive update yesterday. At the time of writing, LBT Innovations shares are d...